GO:0000177 cytoplasmic exosome (RNase complex): Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000177 describes the cytoplasmic exosome, a 3' to 5' processive hydrolytic exoribonuclease complex that degrades or processes single-stranded RNA, preventing translation or export of aberrant transcripts.
• The complex is structurally conserved from yeast to humans and has been resolved by cryo-electron microscopy, revealing a barrel-shaped core with a central channel that threads RNA to the active site.
• The cytoplasmic exosome relies on cofactors such as the SKI complex to deliver mRNA substrates, especially when ribosomes are not directly associated.
• Recent structural work shows that the human exosome can form a supercomplex with the ribosome to degrade mRNA during translation.
• The catalytic subunit DIS3 can degrade circular RNA, expanding the known substrate repertoire beyond linear single-stranded RNA.
• Dysregulation of cytoplasmic exosome components is linked to cancer, antiviral responses, and developmental disorders, making it a target for functional genomics and therapeutic research.
Description
The cytoplasmic exosome (RNase complex), annotated as GO:0000177, is a multisubunit ribonuclease machine that carries out 3' to 5' processive hydrolytic exoribonuclease activity, producing 5'-phosphomonoesters and participating in a multitude of cellular RNA processing and degradation events that prevent nuclear export and/or translation of aberrant RNAs. It is restricted to processing linear and circular single-stranded RNAs, and RNAs with complex secondary structures may require unwinding or pre-processing by cofactors before entering the complex, especially if the 3' end is structured. This complex is a central component of cytoplasmic RNA quality control and turnover, and its dysfunction has been implicated in diverse biological processes and diseases. Researchers study GO:0000177 to understand how cells maintain transcriptome fidelity, how RNA decay is coupled to translation, and how pathogens or oncogenes hijack RNA metabolism. The cytoplasmic exosome is structurally and functionally distinct from the nuclear exosome, although they share a common core architecture and catalytic subunits. Recent advances in cryo-electron microscopy and functional assays have provided near-atomic resolution of the yeast and human complexes, revealing how RNA is threaded through a central channel to the active sites and how cofactors such as the SKI complex and the ribosome modulate substrate selection. These insights have positioned the cytoplasmic exosome as a paradigm for understanding processive ribonuclease mechanisms and as a potential target for therapeutic intervention in cancer and viral infections.
cytoplasmic exosome (RNase complex) At A Glance
| GO ID | GO:0000177 |
|---|---|
| GO term | cytoplasmic exosome (RNase complex) |
| Ontology | cellular_component |
| Synonym | cytoplasmic exosome multienzyme ribonuclease complex; cytoplasmic exosome (ribonuclease complex); prokaryotic exosome multienzyme ribonuclease complex |
| Major function | 3' to 5' processive hydrolytic exoribonuclease activity on single-stranded RNA, producing 5'-phosphomonoesters; prevents nuclear export and/or translation of aberrant RNAs |
| Substrates | Linear and circular single-stranded RNAs; structured RNAs may require cofactor-mediated unwinding |
| Cofactors | SKI complex, ribosome, and other accessory factors that deliver or unwind RNA |
| Cellular localization | Cytoplasm; can associate with ribosomes and mRNA decay machinery |
| Evolutionary conservation | Structurally and functionally conserved from yeast to humans |
What Is GO:0000177?
The cytoplasmic exosome (RNase complex) is a ribonuclease complex that has 3-prime to 5-prime processive hydrolytic exoribonuclease activity producing 5-prime-phosphomonoesters. It participates in a multitude of cellular RNA processing and degradation events preventing nuclear export and/or translation of aberrant RNAs. It is restricted to processing linear and circular single-stranded RNAs (ssRNA) only. RNAs with complex secondary structures may have to be unwound or pre-processed by co-factors prior to entering the complex, especially if the 3-prime end is structured.
Why Is cytoplasmic exosome (RNase complex) Important in Cell Biology?
The cytoplasmic exosome (RNase complex) is essential for maintaining RNA homeostasis and preventing the accumulation of aberrant transcripts that could be translated into toxic proteins or trigger immune responses. Its role in mRNA decay is tightly coupled to translation, as shown by the human exosome-ribosome supercomplex, which ensures that defective mRNAs are degraded co-translationally. The complex also participates in antiviral defense by degrading viral RNAs and in the regulation of gene expression programs, including those driven by oncogenes such as MYC and MYCN. Dysregulation of exosome components has been linked to cancer, developmental disorders, and neurodegeneration, making it a focal point for understanding disease mechanisms and for developing targeted therapies.
• Maintains transcriptome fidelity by degrading aberrant or unstable mRNAs, preventing translation of truncated or misfolded proteins.
• Couples RNA decay to translation through the exosome-ribosome supercomplex, ensuring efficient quality control.
• Serves as a key effector in antiviral responses by degrading viral RNA and modulating innate immune signaling.
• Regulates gene expression programs controlled by oncoproteins such as MYC and MYCN, which interact with exosome targeting factors.
• Its catalytic subunit DIS3 can degrade circular RNAs, linking the exosome to noncoding RNA metabolism.
• Mutations or altered expression of exosome components are associated with cancer, developmental defects, and ribosomopathies.
• The SKI complex acts as a specialized cofactor that assists the cytoplasmic exosome in mRNA metabolism when ribosome association is absent.
• Structural studies have revealed conserved mechanisms of RNA threading and catalysis, providing a framework for inhibitor design.
• The complex is a model system for studying processive exoribonuclease mechanisms and RNA-protein interactions.
• Understanding its regulation offers insights into how cells adapt RNA decay to stress, infection, and oncogenic signaling.
Core Biology of GO:0000177 cytoplasmic exosome (RNase complex)
What Happens During cytoplasmic exosome (RNase complex)?
In simple terms: The cytoplasmic exosome acts like a molecular shredder that chews up RNA from one end, but only after the RNA is fed into its central channel.
The cytoplasmic exosome degrades or processes single-stranded RNA in a 3' to 5' direction, releasing 5'-phosphomonoesters. Substrates are typically aberrant mRNAs, but the complex can also act on circular RNAs, as shown for the catalytic subunit DIS3. The process is processive, meaning the enzyme remains bound to the RNA and continues cleaving until the substrate is fully degraded or reaches a structured region that requires unwinding. In vivo, the exosome often associates with translating ribosomes, forming a supercomplex that degrades mRNA co-translationally. The SKI complex can deliver mRNA substrates to the exosome, particularly when ribosome association is limited.
Substrate Recognition and Channeling
In simple terms: RNA must be threaded through a narrow tunnel to reach the cutting sites, so the exosome only works on single-stranded RNA that can fit.
Cryo-electron microscopy of the yeast cytoplasmic exosome revealed a barrel-shaped core with a central channel that accommodates single-stranded RNA. The RNA is threaded through this channel to the active sites of the catalytic subunits. Structured RNA regions may block entry, necessitating cofactors such as helicases or the SKI complex to unwind or pre-process the 3' end. The channel architecture ensures that only linear or circular single-stranded RNAs are processed, consistent with the GO definition.
Catalytic Mechanism and Cofactors
In simple terms: The exosome has active sites that cut RNA, but it needs helper proteins to bring RNA in and to regulate when and where degradation happens.
The catalytic activity resides in subunits such as DIS3 (in humans) and Rrp44/Dis3 (in yeast), which contain RNase II and RNase III domains. The SKI complex is a key cytoplasmic cofactor that assists the exosome in mRNA metabolism, especially in the absence of direct ribosome association. The SKI complex is a multifaceted cofactor with links to disease, developmental processes, and antiviral responses. The human exosome can also form a supercomplex with the ribosome, which may coordinate mRNA decay with translation termination.
Regulation and Accessory Factors
In simple terms: The exosome does not work alone; proteins like MYC and MYCN can influence how it targets RNA, linking RNA decay to cancer and immune signaling.
The MYCN oncoprotein acts as an RNA-binding accessory factor of the nuclear exosome targeting complex, and similar principles may apply to cytoplasmic functions. MYC binding to nascent RNA suppresses innate immune signaling by R-loop-derived RNA-DNA hybrids, indicating crosstalk between RNA decay and immune surveillance. These findings suggest that oncogenic transcription factors can modulate exosome targeting, although the precise mechanisms for cytoplasmic exosome regulation remain an active area of research.
Key Genes Involved in GO:0000177 cytoplasmic exosome (RNase complex)
The following genes and proteins are core components or well-characterized cofactors of the cytoplasmic exosome (RNase complex) in humans and model organisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DIS3 | Catalytic subunit with 3' to 5' exoribonuclease activity; degrades linear and circular RNA | Target for studying RNA decay mechanisms and cancer-associated mutations |
| EXOSC1 | Core structural subunit of the exosome barrel | Essential for complex assembly and stability |
| EXOSC2 | Core subunit; mutations linked to developmental disorders | Model for ribosomopathy and RNA processing defects |
| EXOSC3 | Core subunit; involved in RNA channeling | Implicated in neurological disorders and RNA quality control |
| EXOSC4 | Core subunit; forms part of the hexameric ring | Required for exosome integrity and function |
| EXOSC5 | Core subunit; contributes to RNA binding | Potential biomarker in cancer and antiviral responses |
| EXOSC6 | Core subunit; stabilizes the complex | Studied for its role in RNA turnover |
| EXOSC7 | Core subunit; part of the barrel structure | Essential for processive degradation |
| EXOSC8 | Core subunit; mutations cause neurodegeneration | Model for pontocerebellar hypoplasia |
| EXOSC9 | Core subunit; involved in RNA processing | Linked to developmental and immune disorders |
| EXOSC10 | Nuclear and cytoplasmic functions; exoribonuclease | Dual localization makes it a key regulatory node |
| SKIV2L | SKI complex helicase; assists exosome in mRNA decay | Links exosome to antiviral immunity and mRNA metabolism |
| TTC37 | SKI complex subunit; tetratricopeptide repeat protein | Mutations cause syndromic diarrhea and immune defects |
| HBS1L | Ribosome-associated factor that can deliver mRNA to exosome | Studied in translation-coupled decay |
| PABPC1 | Poly(A)-binding protein; modulates mRNA stability and exosome access | Target for understanding 3' end processing |
| MYCN | RNA-binding accessory factor of exosome targeting complex | Oncogene that links RNA decay to neuroblastoma |
| MYC | Binds nascent RNA; suppresses innate immune signaling | Oncogene with roles in R-loop and RNA-DNA hybrid metabolism |
How Is cytoplasmic exosome (RNase complex) Regulated?
The cytoplasmic exosome is regulated at multiple levels, including substrate delivery by cofactors such as the SKI complex, which assists the exosome in mRNA metabolism when direct ribosome association is absent. The SKI complex itself is a multifaceted cofactor with links to disease, developmental processes, and antiviral responses, suggesting that its expression or activity can modulate exosome function. The human exosome can form a supercomplex with the ribosome, which may coordinate mRNA decay with translation and provide a regulatory checkpoint. Oncoproteins such as MYCN and MYC can interact with RNA and exosome targeting factors, potentially altering substrate selection and linking RNA decay to oncogenic signaling and innate immune suppression. However, the precise molecular mechanisms of cytoplasmic exosome regulation, including post-translational modifications and stress-induced changes, remain incompletely understood and are an active area of research.
cytoplasmic exosome (RNase complex) and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EXOSC3 | Pontocerebellar hypoplasia and motor neuron degeneration | Knockout or point-mutation in neuronal cell lines and organoids |
| EXOSC8 | Neurodegeneration and developmental delay | Knock-in of patient mutations in iPSC-derived neurons |
| SKIV2L | Syndromic diarrhea and immune dysregulation | Knockout in intestinal epithelial cells and immune cells |
| DIS3 | Cancer-associated mutations and RNA decay defects | Overexpression or point mutation in cancer cell lines |
| MYCN | Neuroblastoma and RNA metabolism | Knockout or knockdown in neuroblastoma cell lines |
Cancer and Oncogenic Signaling
Components of the cytoplasmic exosome and its cofactors are implicated in cancer. The MYCN oncoprotein acts as an RNA-binding accessory factor of the nuclear exosome targeting complex, and its interaction with RNA decay machinery may contribute to neuroblastoma pathogenesis. MYC binding to nascent RNA suppresses innate immune signaling by R-loop-derived RNA-DNA hybrids, revealing a mechanism by which oncogenes can co-opt RNA metabolism to evade immune detection. Dysregulation of exosome-mediated RNA decay could therefore promote tumorigenesis by stabilizing oncogenic transcripts or altering immune surveillance.
Developmental Disorders and Ribosomopathies
Mutations in core exosome subunits such as EXOSC2, EXOSC3, EXOSC8, and EXOSC9 have been linked to developmental disorders, including pontocerebellar hypoplasia and syndromic diarrhea. The SKI complex, a key cofactor, is also associated with disease and developmental processes, underscoring the importance of cytoplasmic RNA decay in normal development. These disorders highlight the non-redundant roles of exosome components in RNA processing and quality control.
Antiviral Responses and Innate Immunity
The cytoplasmic exosome and its SKI complex cofactor play roles in antiviral responses by degrading viral RNA and modulating innate immune signaling. MYC binding to nascent RNA suppresses innate immune signaling by R-loop-derived RNA-DNA hybrids, suggesting that RNA decay pathways can influence immune detection of aberrant nucleic acids. Understanding how the exosome interacts with viral RNAs and immune sensors could inform antiviral strategies.
From cytoplasmic exosome (RNase complex)-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of exosome core subunit loss on transcriptome stability? | CRISPR knockout of EXOSC genes in HEK293 or HeLa cells followed by RNA-seq |
| How do disease-associated point mutations in EXOSC3 affect RNA binding and decay? | Point-mutation knock-in in iPSC-derived neurons or patient fibroblasts |
| Does the SKI complex interact with the exosome in a stimulus-dependent manner? | Endogenous tagged knock-in of SKIV2L or TTC37 followed by immunoprecipitation |
| Can overexpression of DIS3 enhance degradation of circular RNA? | Overexpression of wild-type or mutant DIS3 in cancer cell lines |
| What is the role of MYCN in exosome targeting in neuroblastoma? | Knockout or knockdown of MYCN in neuroblastoma cells with RNA-seq and CLIP |
| How does the exosome-ribosome supercomplex assemble? | Knock-in of tagged ribosomal proteins and exosome subunits for cryo-EM or crosslinking |
How to Study the cytoplasmic exosome (RNase complex) Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Steady-state RNA levels and 3' end processing | Assessing transcriptome changes after exosome knockout |
| Ribo-seq | Ribosome occupancy and translation efficiency | Studying co-translational mRNA decay |
| CLIP-seq | RNA binding sites of exosome-associated proteins | Mapping MYCN or MYC interactions with RNA |
| Immunoprecipitation-mass spectrometry | Protein-protein interactions | Identifying SKI complex and ribosome association |
| Cryo-electron microscopy | High-resolution structure of the complex | Visualizing RNA channel and active sites |
| Fluorescence microscopy | Subcellular localization and dynamics | Tracking exosome co-localization with ribosomes |
| Circular RNA degradation assay | Stability of circular RNAs | Testing DIS3 activity on circular substrates |
| CRISPR knockout screening | Gene essentiality and genetic interactions | Identifying synthetic lethal partners of exosome subunits |
RNA Sequencing and Transcriptome Analysis
RNA-seq is widely used to assess the impact of exosome perturbation on transcript stability and processing. Knockout or knockdown of core subunits such as EXOSC3 or DIS3 leads to accumulation of aberrant transcripts, which can be detected by differential expression and 3' end mapping. Circular RNA degradation by DIS3 can be monitored using RNase R treatment followed by RNA-seq.
Ribosome Profiling and Translation Studies
Ribo-seq measures ribosome occupancy and can reveal defects in co-translational mRNA decay when the exosome-ribosome supercomplex is disrupted. Combining Ribo-seq with RNA-seq provides a global view of how exosome dysfunction affects translation efficiency and mRNA stability.
Proteomics and Structural Biology
Affinity purification coupled to mass spectrometry can identify exosome interactors, including the SKI complex and ribosome components. Cryo-electron microscopy has been instrumental in resolving the architecture of the yeast and human cytoplasmic exosome, revealing the RNA channel and active site organization.
Imaging and Cellular Localization
Fluorescence microscopy of tagged exosome subunits can reveal their subcellular localization and co-localization with ribosomes or stress granules. Live-cell imaging can track the dynamics of exosome recruitment to mRNA substrates.
How CRISPR Can Be Used to Study GO:0000177 cytoplasmic exosome (RNase complex)
Knockout
CRISPR knockout of core exosome genes such as EXOSC3, EXOSC8, or DIS3 can reveal their essential roles in RNA decay and cell viability. Knockout cell lines are valuable for transcriptome-wide studies and for identifying compensatory pathways. However, some subunits may be essential, requiring inducible or conditional knockout systems.
Point Mutation
Point mutations identified in patients, such as those in EXOSC3 or EXOSC8, can be introduced into cell lines or iPSCs to model disease and dissect structure-function relationships. These models help determine whether specific mutations affect RNA binding, catalysis, or complex assembly.
Knock-in
Knock-in of epitope tags or fluorescent proteins into endogenous exosome subunit loci allows for affinity purification, imaging, and proteomics under near-physiological conditions. Tagged knock-in models are particularly useful for studying dynamic interactions with the SKI complex and ribosomes.
Overexpression
Overexpression of wild-type or mutant exosome subunits, such as DIS3 or MYCN, can be used to study gain-of-function effects on RNA metabolism and oncogenic signaling. Overexpression models are also useful for testing whether increased exosome activity can suppress aberrant RNA accumulation.
How EDITGENE Supports cytoplasmic exosome (RNase complex) Research
Researchers studying cytoplasmic exosome (RNase complex)-related genes often need to determine whether a candidate gene is causally involved in RNA decay, disease, or drug response. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic manipulation and functional interrogation of exosome components and their cofactors.
Contact EDITGENE today to design your custom CRISPR model for cytoplasmic exosome (RNase complex) research.
Frequently Asked Questions About cytoplasmic exosome (RNase complex)
What is the cytoplasmic exosome (RNase complex)?
The cytoplasmic exosome (RNase complex), GO:0000177, is a multisubunit ribonuclease complex that degrades or processes single-stranded RNA in a 3' to 5' direction, producing 5'-phosphomonoesters and preventing translation of aberrant RNAs.
What genes are involved in the cytoplasmic exosome (RNase complex)?
Core genes include EXOSC1-EXOSC10 and DIS3, while cofactors include SKIV2L, TTC37, and HBS1L. Oncogenes such as MYCN and MYC can also interact with the complex.
What is the function of GO:0000177?
GO:0000177 functions in RNA quality control and turnover, degrading linear and circular single-stranded RNAs and preventing nuclear export or translation of aberrant transcripts.
How does the cytoplasmic exosome differ from the nuclear exosome?
The cytoplasmic exosome is localized in the cytoplasm and primarily targets mRNAs and other cytoplasmic RNAs, while the nuclear exosome functions in the nucleus on pre-ribosomal RNA and other nuclear transcripts. They share core subunits but differ in cofactors and substrates.
What diseases are linked to cytoplasmic exosome dysfunction?
Mutations in EXOSC3, EXOSC8, and other subunits are linked to developmental disorders and neurodegeneration, while dysregulation of DIS3 and MYCN is associated with cancer.
How is the cytoplasmic exosome regulated?
It is regulated by cofactors such as the SKI complex, by association with ribosomes, and potentially by oncoproteins like MYC and MYCN that influence substrate selection.
What methods are used to study the cytoplasmic exosome?
Common methods include RNA-seq, Ribo-seq, CLIP-seq, immunoprecipitation-mass spectrometry, cryo-electron microscopy, and CRISPR knockout screens.
Can the cytoplasmic exosome degrade circular RNA?
Yes, the catalytic subunit DIS3 can degrade circular RNA, expanding the known substrate range beyond linear single-stranded RNA.
What is the SKI complex and how does it relate to the exosome?
The SKI complex is a cytoplasmic cofactor that assists the exosome in mRNA metabolism, particularly when the exosome is not directly associated with ribosomes. It is linked to disease and antiviral responses.
How can CRISPR be used to study the cytoplasmic exosome?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to dissect the roles of exosome subunits and cofactors in RNA decay, disease, and drug response.
Conclusion
The cytoplasmic exosome (RNase complex), GO:0000177, is a central machine for RNA quality control and turnover in the cytoplasm. Its ability to processively degrade single-stranded RNA, including circular RNA, and its dynamic interactions with the SKI complex and ribosomes make it a key node in gene expression regulation. Dysregulation of its components is linked to cancer, developmental disorders, and antiviral immunity, underscoring its biomedical importance. Continued research using CRISPR models, structural biology, and functional genomics will further illuminate its mechanisms and therapeutic potential.
References
- 1. Papadopoulos D et al.. 2024. The MYCN oncoprotein is an RNA-binding accessory factor of the nuclear exosome targeting complex.. Mol Cell 84(11):2070-2086.e20 PMID: 38703770
- 2. Tomecki R et al.. 2023. SKI complex: A multifaceted cytoplasmic RNA exosome cofactor in mRNA metabolism with links to disease, developmental processes, and antiviral responses.. Wiley Interdiscip Rev RNA 14(6):e1795 PMID: 37384835
- 3. Tao X et al.. 2025. Degradation of circular RNA by the ribonuclease DIS3.. Mol Cell 85(8):1674-1685.e8 PMID: 39965568
- 4. Liu JJ et al.. 2016. CryoEM structure of yeast cytoplasmic exosome complex.. Cell Res 26(7):822-37 PMID: 27174052
- 5. Uhl L et al.. 2026. MYC binding to nascent RNA suppresses innate immune signaling by R-loop-derived RNA-DNA hybrids.. Cell 189(5):1371-1388.e29 PMID: 41576951
- 6. Schaeffer D et al.. 2011. Functions of the cytoplasmic exosome.. Adv Exp Med Biol 702:79-90 PMID: 21713679
- 7. Kögel A et al.. 2024. Structural basis of mRNA decay by the human exosome-ribosome supercomplex.. Nature 635(8037):237-242 PMID: 39385025
- 8. Zhang E et al.. 2019. A specialised SKI complex assists the cytoplasmic RNA exosome in the absence of direct association with ribosomes.. EMBO J 38(14):e100640 PMID: 31304628
